Ranbaxy - Placing correct bets at FinGad.com

Vote

Categorie: Emerging Markets
Submitted 10 months ago by

Prakash , Senior Research Analyst

Ranbaxy Laboratories Ltd Industry The Global Pharmaceutical market audited sales grew by 7% (at constant exchange rates) to reach US $ 608 billion. North America, Europe and Japan continued to remain the key markets accounting for 87% of the worldwide pharmaceutical sales. The buoyant growth recorded in the US pharmaceutical market, led by an increase in prescribing volume due to Medicare Part D, and a strong growth in the oncology products globally, were the key contributors to market expansion. The North American pharmaceutical sales grew by 8.0% to reach US $ 290 Billion, constituting 48% of the global sales. Growth was fuelled by the Medicare Part D prescription benefit, the increased utilization of generics within new therapy classes and the launch of drugs targeted at specific diseases, e.g. cancer and diabetes. Europe clocked sales of US $ 182 Billion, a growth of 4.8%, and contributed 30% to total global pharmaceutical sales. Japan, the world's second largest market, which has historically posted slower growth rates, continued its weak performance with de-growt... More...

[ 0 Comments | Send To A Friend | Bookmark Review ]

0 comments ↓

Please Login or Register to comment